Core Viewpoint - Rosen Law Firm is reminding purchasers of Class A common stock of The Trade Desk, Inc. about the lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during a specified class period [1][5]. Group 1: Class Action Details - The class action lawsuit pertains to investors who purchased Trade Desk Class A common stock between May 9, 2024, and February 12, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the court by April 21, 2025, to represent other class members in the litigation [3]. Group 2: Allegations Against Trade Desk - The lawsuit alleges that Trade Desk made false and misleading statements regarding its business operations and the rollout of its AI forecasting tool, Kokai [5]. - Specific claims include significant execution challenges in rolling out Kokai, which delayed its deployment and negatively impacted revenue growth [5]. - The lawsuit asserts that the positive statements made by Trade Desk lacked a reasonable basis and were materially false and misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [4]. - The firm has been ranked highly for the number of securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in litigation [4].

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against The Trade Desk, Inc. (NASDAQ: TTD) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Trade Desk, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/the-trade-desk-inc Investors have until April 21, 2025, to ask the Court to be appoin ...

Market Overview - The stock market has experienced historic volatility, with the S&P 500 losing 10.5% in just two trading days, marking its fifth-largest two-day decline in 75 years [2] - President Trump's temporary reversal of tariff policies led to significant single-session gains for major indices on April 9, with the Dow Jones increasing by 2,963 points, S&P 500 by 474 points, and Nasdaq Composite by 1,857 points, all record highs [3] Investment Opportunities - Despite the market being historically pricey, price dislocations have emerged, allowing for the purchase of undervalued stocks [4] Pfizer - Pfizer is viewed as mispriced, with concerns over potential tariffs on pharmaceuticals being considered overblown; the company was nearing an 8% dividend yield [5] - Sales from COVID-19 therapies dropped from over $56 billion in 2022 to approximately $11 billion last year, yet Pfizer's net sales increased by 52% to $63.6 billion from 2020 to 2024 [6][7] - The acquisition of Seagen is expected to enhance Pfizer's growth, with a forward P/E ratio just above 7 being attractive [8] Sirius XM Holdings - Sirius XM is identified as having a price dislocation, with its unique position as the only licensed satellite-radio operator providing it with pricing power [9][10] - The company generates 76% of its net sales from subscriptions, making its cash flow more predictable during economic downturns; shares were trading at a forward P/E of 6, the lowest since going public [12] Intel - Intel's shares are trading below book value, presenting a buying opportunity despite challenges from competitors [13] - The company remains a dominant player in CPUs for laptops and desktops, and new CEO Lip-Bu Tan is expected to improve operations and margins [15] - Intel's potential in AI remains, despite current struggles in the market [16] Fastly - Fastly is recognized for its content delivery network and security solutions, with a compelling long-term outlook despite recent growth disappointments [18][19] - The company has a net retention rate of 102% and a consistent annual revenue retention rate above 99%, indicating customer loyalty [20] - Shares are trading below book value and at a low sales multiple, making it an attractive investment [21] BioMarin Pharmaceutical - BioMarin focuses on orphan-disease therapies, which leads to predictable demand and strong pricing power [23] - The company reported $2.85 billion in sales last year, an 18% increase, with its top-selling drug Voxzogo contributing significantly [24] - BioMarin's valuation is at historic lows, with a forecasted P/E of just over 10 for 2026 [25] PubMatic - PubMatic is positioned well in the digital advertising space, focusing on connected TV and mobile, with a significant growth segment [28] - The company has developed its own cloud infrastructure, which is expected to enhance margins as it scales [29] - With a strong cash position and positive operating cash flow for a decade, shares were valued at 10 times forecast EPS, presenting a clear price dislocation [30]

Core Viewpoint - Rosen Law Firm is reminding purchasers of Class A common stock of The Trade Desk, Inc. about the upcoming lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during a specified period [1][5]. Group 1: Class Action Details - The class action pertains to investors who purchased Trade Desk Class A common stock between May 9, 2024, and February 12, 2025, and they may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. - A lead plaintiff must file a motion with the Court by April 21, 2025, to represent other class members in the litigation [3]. Group 2: Allegations Against The Trade Desk - The lawsuit alleges that Trade Desk made false and misleading statements regarding its business operations, particularly concerning the rollout of its generative AI forecasting tool, Kokai [5]. - Specific claims include significant execution challenges in deploying Kokai, delays in its rollout, and negative impacts on revenue growth, which contradicted the positive statements made by the company [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes its experience and success in handling securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked highly for securities class action settlements [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has received recognition for its attorneys [4].

Group 1: Market Overview - The stock market experienced a significant downturn in 2025, with the Nasdaq Composite and S&P 500 indices entering corrections, falling more than 10% from their highs [1] - Investors are currently cautious, with recommendations to maintain cash reserves and seek high-quality companies at attractive valuations [2] Group 2: The Trade Desk Performance - The Trade Desk's stock recently dropped 50% from its recent high due to a fourth-quarter 2024 earnings miss and broader market sell-off [4] - Despite missing estimates, Q4 2024 sales reached $741 million, reflecting a 22% year-over-year growth, and operating income increased from $144 million in Q4 2023 to $195 million in Q4 2024 [5] - The Trade Desk achieved record results in 2024, with trailing-12-month sales of $2.4 billion, a 26% increase over 2023, and operating income of $427 million, a 113% increase [6] Group 3: Industry Dynamics - The advertising industry, particularly programmatic advertising on streaming platforms, is experiencing growth, benefiting companies like The Trade Desk [7][8] - The Trade Desk provides valuable data and feedback to clients, enhancing its position in the market as streaming services gain popularity [8] Group 4: Valuation and Investment Potential - The Trade Desk's stock is now trading at a price-to-sales ratio of 9 on a forward basis, which is significantly lower than recent valuations [10] - The market's current pricing of The Trade Desk stock suggests it is undervalued despite the company's solid track record and ongoing growth potential [10]

Group 1: Arm Holdings - Arm Holdings has a median target price implying a 106% upside from its current share price of $86, with analysts optimistic about its growth potential [3][11] - The company reported a 19% increase in revenue to $983 million, driven by strong growth in royalties and adoption of its latest CPU architecture, Armv9 [5] - Arm's technology is gaining traction in data centers, particularly for AI workloads, as major public clouds have deployed Arm-based chips [4][6][7] Group 2: The Trade Desk - The Trade Desk has a median target price suggesting a 124% upside from its current share price of $46, despite a 67% decline from its high [9][11] - The company reported a 22% revenue increase to $741 million, but fell short of its own sales guidance for the first time in 33 quarters [10] - Wall Street expects The Trade Desk's earnings to grow at 14% annually through 2026, with potential for faster growth due to increasing adtech spending [12][13]

Core Viewpoint - A class action securities lawsuit has been filed against The Trade Desk, Inc. for alleged securities fraud affecting investors between May 9, 2024, and February 12, 2025 [1] Group 1: Allegations and Impact - The lawsuit claims that The Trade Desk faced significant execution challenges in rolling out its AI forecasting tool, Kokai, which included transitioning clients from the older platform, Solimar [2] - These execution challenges reportedly delayed the Kokai rollout, negatively impacting the company's business operations and revenue growth [2] - Positive statements made by the defendants regarding the company's business and prospects were allegedly materially false and misleading due to the aforementioned issues [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until April 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - The Trade Desk, Inc. is facing a federal securities class action due to misleading statements regarding the rollout of its generative AI forecasting tool, Kokai, which has resulted in significant revenue misses and a sharp decline in stock price [1][4]. Group 1: Company Performance and Developments - On June 6, 2024, Trade Desk launched Kokai, transitioning clients from its older platform, Solimar, and claimed a seamless transition [3]. - On February 12, 2025, Trade Desk reported fourth quarter revenue of $741 million, missing guidance of $756 million and analysts' estimates of $759.8 million [3]. - The company’s revenue guidance for Q1 2024 was at least $575 million, which also fell short of analysts' expectations of $581.5 million [3]. - CEO Jeff Green acknowledged that the rollout of Kokai was slower than anticipated, stating that the company was still maintaining both systems, which hindered progress [3][4]. - Following the earnings call, Trade Desk's stock price dropped by approximately 32%, from $121.23 to $81.92 per share [3]. Group 2: Legal Implications - The class action complaint alleges that Trade Desk made materially misleading statements about the rollout of Kokai, failing to disclose significant execution challenges [4]. - The complaint highlights that these challenges delayed the rollout and negatively impacted the company's business and revenue growth [4].

Core Viewpoint - A class action lawsuit has been filed against The Trade Desk, Inc. for allegedly misleading investors about its business prospects during a specific period [1][2]. Group 1: Allegations and Challenges - The lawsuit claims that The Trade Desk failed to disclose significant execution challenges related to the rollout of its new platform, Kokai, which affected client transitions from the older platform, Solimar [2]. - These execution challenges reportedly delayed the Kokai rollout and negatively impacted the company's business operations and revenue growth [2]. - The positive statements made by the company regarding its business and prospects were deemed materially false and misleading due to these undisclosed issues [2]. Group 2: Financial Performance - On February 12, 2025, The Trade Desk reported fourth quarter revenue of $741 million, which was below its guidance of $756 million and analysts' expectations of $759.8 million [3]. - The company's revenue guidance for the first quarter of 2025 was at least $575 million, missing analysts' estimates of $581.5 million [3]. - Following the announcement of these results and the acknowledgment of the slower Kokai rollout, the stock price dropped by $40.31, or over 32%, from $122.23 to $81.92 per share [3]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must file their papers by April 21, 2025, to serve as lead plaintiffs [4]. - Shareholders can remain absent class members if they choose not to participate in the case [4]. Group 4: Company Background - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - The Trade Desk, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its AI forecasting tool, Kokai, and its impact on the company's business operations and revenue growth [3][4]. Summary by Sections Class Action Details - The class period for the lawsuit is from May 9, 2024, to February 12, 2025 [3]. - Shareholders who purchased shares during this period are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment [1][4]. Allegations Against The Trade Desk - The complaint alleges that The Trade Desk faced significant execution challenges in rolling out its AI tool, Kokai, which included difficulties in transitioning clients from the older platform, Solimar [3]. - These execution challenges delayed the rollout of Kokai and negatively impacted the company's business operations, particularly revenue growth [3]. - The positive statements made by the company regarding its business and prospects were claimed to be materially false and misleading due to these issues [3]. Next Steps for Shareholders - Shareholders are advised to register for the class action by April 21, 2025, to participate in the case without any cost or obligation [4]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [4]. About The Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].